These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7278494)

  • 1. Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type.
    Rossor MN; Rehfeld JF; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Life Sci; 1981 Jul; 29(4):405-10. PubMed ID: 7278494
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1980 Dec; 20(3):373-7. PubMed ID: 6108540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Exp Brain Res; 1982; Suppl 5():153-7. PubMed ID: 6129994
    [No Abstract]   [Full Text] [Related]  

  • 4. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
    Ruberg M; Ploska A; Javoy-Agid F; Agid Y
    Brain Res; 1982 Jan; 232(1):129-39. PubMed ID: 7055689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
    Rossor M; Fahrenkrug J; Emson P; Mountjoy C; Iversen L; Roth M
    Brain Res; 1980 Nov; 201(1):249-53. PubMed ID: 7417838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia.
    Rossor MN; Iversen LL; Mountjoy CQ; Roth M; Hawthorn J; Ang VY; Jenkins JS
    Lancet; 1980 Dec 20-27; 2(8208-8209):1367-8. PubMed ID: 6109178
    [No Abstract]   [Full Text] [Related]  

  • 8. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
    J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Davies P; Terry RD
    Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.
    Sakurada T; Alufuzoff I; Winblad B; Nordberg A
    Brain Res; 1990 Jun; 521(1-2):329-32. PubMed ID: 1698512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.
    Nordberg A; Nyberg P; Adolfsson R; Winblad B
    J Neural Transm; 1987; 69(1-2):19-32. PubMed ID: 3585318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A
    Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P; Katzman R; Terry RD
    Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter and neuropeptide systems in Alzheimer-type dementia.
    Perry EK; Perry RH
    Exp Brain Res; 1982; Suppl 5():140-5. PubMed ID: 6185355
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease.
    Richter JA; Perry EK; Tomlinson BE
    Life Sci; 1980 May; 26(20):1683-9. PubMed ID: 7392805
    [No Abstract]   [Full Text] [Related]  

  • 16. Choline in Alzheimer's disease.
    Spillane JA; Goodhart MJ; White P; Bowen DM; Davison AN
    Lancet; 1977 Oct; 2(8042):826-7. PubMed ID: 71636
    [No Abstract]   [Full Text] [Related]  

  • 17. [3H]Kainic acid binding and choline acetyltransferase activity in Alzheimer's dementia.
    Pearce BR; Bowen DM
    Brain Res; 1984 Sep; 310(2):376-8. PubMed ID: 6488028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
    Armstrong DM; Bruce G; Hersh LB; Terry RD
    Neurosci Lett; 1986 Nov; 71(2):229-34. PubMed ID: 2431362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.
    Perry EK; Gibson PH; Blessed G; Perry RH; Tomlinson BE
    J Neurol Sci; 1977 Nov; 34(2):247-65. PubMed ID: 144789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.